全球基因型鑒定檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

基因型鑒定檢測市場預計將從 2025 年的 516.6 億美元成長到 2034 年的 3,331.6 億美元，2026 年至 2034 年的複合年成長率為 23.01%。

受醫學研究和疾病診斷中基因檢測應用日益廣泛的推動，全球基因型鑒定檢測市場正迅速擴張。基因型鑒定檢測有助於識別影響疾病易感性、藥物反應和遺傳性疾病的基因變異。這些檢測方法廣泛應用於臨床診斷、藥物研發和生物技術領域。

基因組學的進步和個人化醫療需求的日益成長是推動市場成長的主要因素。遺傳學領域的研究不斷深入，以及對疾病早期檢測的日益重視，顯著提高了基因型鑒定檢測的應用率。此外，政府對基因組學研究的資助以及實驗室技術的進步也促進了市場發展。

隨著基因組醫學的日益普及，基因型鑒定檢測市場預計將迎來強勁成長。將次世代定序技術和人工智慧應用於基因分析，將顯著提升基因型鑒定檢測的準確性和效率。罕見疾病和精準醫療研究的不斷深入，也將持續為該市場創造新的機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球基因型鑒定檢測市場：依產品與服務分類

• 市場分析、洞察與預測
• 試劑和試劑盒
• 基因型鑒定服務
• 裝置
• 生物資訊學

第5章 全球基因型鑒定檢測市場：依技術分類

• 市場分析、洞察與預測
• PCR
• 微陣列
• 定序
• 毛細管電泳
• MALDI-TOF
• 其他方法（芳特異性寡核苷酸（ASO）探針、螢光原位雜合反應（FISH）等）

第6章 全球基因型鑒定檢測市場：依應用分類

• 市場分析、洞察與預測
• 藥物基因體學
• 診斷及個人化醫療
• 農業生物技術
• 動物遺傳學
• 其他領域（產前檢測、法醫學、微生物基因組研究、水產養殖育種研究等）

第7章 全球基因型鑒定檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物製藥公司
• 診斷與研究機構
• 學術機構
• 其他（例如，動物和漁業遺傳公司）

第8章 全球基因型鑒定檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Illumina Inc
  • Thermo Fisher Scientific Inc
  • Qiagen NV
  • Agilent Technologies Inc
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare Technologies Inc
  • Standard BioTools Inc
  • PerkinElmer Inc
  • Eurofins Scientific SE
  • Bio-Rad Laboratories Inc
  • Pacific Biosciences Of California Inc
  • Genewiz Inc
  • Integrated DNA Technologies Inc

The Genotyping Assay Market size is expected to reach USD 333.16 Billion in 2034 from USD 51.66 Billion (2025) growing at a CAGR of 23.01% during 2026-2034.

The global genotyping assay market is expanding rapidly due to the increasing use of genetic testing in medical research and disease diagnosis. Genotyping assays help identify genetic variations that influence disease susceptibility, drug response, and inherited conditions. These assays are widely used in clinical diagnostics, pharmaceutical research, and biotechnology applications.

The growth of the market is driven by advancements in genomic technologies and the rising demand for personalized medicine. Increasing research in genetics and the growing focus on early disease detection have significantly increased the adoption of genotyping assays. Additionally, government funding for genomic research and improvements in laboratory technologies are further supporting market development.

Looking ahead, the genotyping assay market is expected to witness strong growth as genomic medicine becomes more widely adopted. The integration of next-generation sequencing technologies and artificial intelligence in genetic analysis will enhance the accuracy and efficiency of genotyping tests. Expanding research in rare diseases and precision medicine will continue to create new opportunities for this market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Reagents & Kits
• Genotyping Services
• Instruments
• Bioinformatics

By Technology

• PCR
• Microarrays
• Sequencing
• Capillary Electrophoresis
• MALDI-TOF
• Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)

By Application

• Pharmacogenomics
• Diagnostic & Personalized Medicine
• Agricultural Biotechnology
• Animal Genetics
• Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)

By End-user

• Pharmaceutical & Biopharmaceutical Companies
• Diagnostic & Research Laboratories
• Academic Institutes
• Others (Animal and Aquagenetics Companies, etc.)

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, Qiagen NV, Agilent Technologies Inc, Danaher Corporation, F HoffmannLa Roche Ltd, GE HealthCare Technologies Inc, Standard BioTools Inc, PerkinElmer Inc, Eurofins Scientific SE, BioRad Laboratories Inc, Pacific Biosciences of California Inc, Genewiz Inc, Integrated DNA Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENOTYPING ASSAY MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Genotyping Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Bioinformatics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENOTYPING ASSAY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Capillary Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. MALDI-TOF Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENOTYPING ASSAY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Pharmacogenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic & Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Agricultural Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Animal Genetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENOTYPING ASSAY MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Pharmaceutical & Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic & Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others (Animal and Aquagenetics Companies, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENOTYPING ASSAY MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product & Service
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product & Service
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product & Service
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product & Service
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product & Service
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENOTYPING ASSAY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Illumina Inc
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 Qiagen N.V
  • 10.2.4 Agilent Technologies Inc
  • 10.2.5 Danaher Corporation
  • 10.2.6 F. Hoffmann-La Roche Ltd
  • 10.2.7 GE HealthCare Technologies Inc
  • 10.2.8 Standard BioTools Inc
  • 10.2.9 PerkinElmer Inc
  • 10.2.10 Eurofins Scientific SE
  • 10.2.11 Bio-Rad Laboratories Inc
  • 10.2.12 Pacific Biosciences Of California Inc
  • 10.2.13 Genewiz Inc
  • 10.2.14 Integrated DNA Technologies Inc